FORM 8-K
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) January 9, 2003

MERCK & CO., Inc.

(Exact Name of Registrant as Specified in Its Charter)

New Jersey

(State or Other Jurisdiction of Incorporation)
     
1-3305   22-1109110

 
(Commission File Number)   (I.R.S. Employer
Identification No.)
 
One Merck Drive, PO Box 100, Whitehouse Station, NJ      08889-0100

(Address of Principal Executive Offices)                               (Zip Code)

Registrant’s telephone number, including area code (908)423-1000

 


TABLE OF CONTENTS

Item 5. Other Events
Item 7. Financial Statements and Exhibits
SIGNATURES
EXHIBIT INDEX
PRESS RELEASE


Table of Contents

Item 5. Other Events

Incorporated by reference is a press release issued by the Registrant on January 9, 2003, attached as Exhibit 99, regarding the Registrant’s announcement that it plans to launch a tender offer to purchase the remaining 49 percent of the common shares of Banyu Pharmaceutical Co., Ltd. that it does not already own.

Item 7. Financial Statements and Exhibits

  (c)   Exhibits
           
Exhibit 99   Press release issued
January 9, 2003
  Filed with
this document
 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    MERCK & CO., INC.
 
 
Date: January 10, 2003   By:   /s/ Debra A. Bollwage
        DEBRA A. BOLLWAGE
Assistant Secretary

 


Table of Contents

EXHIBIT INDEX

     
Exhibit    
Number   Description

 
99   Press release issued January 9, 2003